Linjardy 5/10mg Tablet

Linjardy 5/10mg Tablet is a combination medication containing two active ingredients: Empagliflozin & Linagliptin. It is prescribed for the management of type 2 diabetes mellitus in adults to help control blood sugar levels.

Key Ingredients:

• Empagliflozin: Empagliflozin belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels.
• Linagliptin: Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which stimulate the pancreas to produce more insulin and reduce the amount of glucose produced by the liver.

Uses:

• Type 2 Diabetes: Linjardy 5/10mg Tablet is used to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower blood sugar levels by two different mechanisms, enhancing insulin secretion and reducing glucose reabsorption in the kidneys.

Administration:

• Linjardy 5/10mg Tablet is typically taken orally, once daily, with or without food, as directed by a healthcare professional.
• The dosage may vary depending on individual patient factors such as kidney function, response to treatment, and other medications being taken for diabetes management.
• It is essential to follow the prescribed regimen provided by the healthcare provider to achieve optimal glycemic control and reduce the risk of complications associated with diabetes.

Precautions:

• Before starting treatment with Linjardy 5/10mg Tablet, inform your healthcare provider about any existing medical conditions, especially kidney problems or a history of diabetic ketoacidosis.
• Inform your healthcare provider about all medications, supplements, and herbal products you are currently taking, as they may interact with Empagliflozin and Linagliptin.
• Monitor blood sugar levels regularly as directed by your healthcare provider while taking Linjardy 5/10mg Tablet to ensure effective glycemic control.
• Report any signs of adverse effects such as urinary tract infections, genital yeast infections, or symptoms of hypoglycemia (low blood sugar) to your healthcare provider promptly.

In Conclusion:

Linjardy 5/10mg Tablet combines the complementary actions of Empagliflozin and Linagliptin to effectively manage blood sugar levels in adults with type 2 diabetes mellitus. By targeting multiple pathways involved in glucose regulation, it offers a comprehensive approach to diabetes management.